Operating Lease, Liability in USD of Can-Fite BioPharma Ltd. from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Liability history and growth rate from Q4 2019 to Q4 2024.
  • Can-Fite BioPharma Ltd. Operating Lease, Liability for the quarter ending December 31, 2024 was $104K, a 160% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)

Can-Fite BioPharma Ltd. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $104K +$64K +160% Dec 31, 2024 20-F 2025-04-14
Q4 2023 $40K -$22K -35.5% Dec 31, 2023 20-F 2024-03-28
Q4 2022 $62K -$62K -50% Dec 31, 2022 20-F 2023-03-30
Q4 2021 $124K +$57K +85.1% Dec 31, 2021 20-F 2022-03-24
Q4 2020 $67K -$8K -10.7% Dec 31, 2020 20-F 2021-03-25
Q4 2019 $75K Dec 31, 2019 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.